Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +2.79% |
|
+0.30% | -35.41% |
06-11 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
06-11 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2025 * | 198K 15.59M | Sales 2026 * | 264K 20.79M | Capitalization | 89.72M 7.07B |
---|---|---|---|---|---|
Net income 2025 * | -67M -5.28B | Net income 2026 * | -82M -6.46B | EV / Sales 2025 * | 147 x |
Net cash position 2025 * | 60.6M 4.78B | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 340 x |
P/E ratio 2025 * |
-1.52
x | P/E ratio 2026 * |
-1.76
x | Employees | 40 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 99.79% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | +2.79% | ||
1 week | +0.30% | ||
Current month | -13.99% | ||
1 month | -18.63% | ||
3 months | -22.43% | ||
6 months | -37.24% | ||
Current year | -35.41% |
![Extreme 3.151](/images/extremecours_fleche.png)
![Extreme 3.151](/images/extremecours_fleche.png)
![Extreme 3.151](/images/extremecours_fleche.png)
![Extreme 1.6284](/images/extremecours_fleche.png)
![Extreme 1.62](/images/extremecours_fleche.png)
![Extreme 1.62](/images/extremecours_fleche.png)
![Extreme 1.62](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 31/12/99 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 20/08/23 |
Joshua Prince
COO | Chief Operating Officer | 54 | 31/10/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 31/05/00 |
Jerry Gin
BRD | Director/Board Member | 81 | 29/02/16 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 31/12/99 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +4.97% | - |
Date | Price | Change | Volume |
---|---|---|---|
25/06/24 | 3.32 | +2.79% | 82,632 |
24/06/24 | 3.23 | -3.58% | 92,750 |
21/06/24 | 3.35 | +4.04% | 118,845 |
20/06/24 | 3.22 | -2.72% | 84,478 |
18/06/24 | 3.31 | -3.22% | 146,935 |
Delayed Quote Nasdaq, June 25, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.41% | 87.29M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- VTGN Stock